CATRINA LEWIS: Open Payments
NPI 1548019516 · BOSSIER CITY, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,473 in 149 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $604 · 2025 $3,473
Food & beverage: $3,157Education: $317
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 31 | $573 |
| Actelion Pharmaceuticals US, Inc. | 15 | $536 |
| AstraZeneca Pharmaceuticals LP | 20 | $505 |
| GENZYME CORPORATION | 11 | $327 |
| Insmed, Inc. | 14 | $284 |
| Regeneron Healthcare Solutions, Inc. | 10 | $271 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $261 |
| Verona Pharma, Inc. | 16 | $207 |
| Merck Sharp & Dohme LLC | 7 | $161 |
| United Therapeutics Corporation | 5 | $153 |
Products named: DUPIXENT, OPSUMIT, NUCALA, Arikayce, TEZSPIRE, Ohtuvayre, TRELEGY ELLIPTA, WINREVAIR.
Industry payments across LA — which companies pay providers there.
